Lv2
164 积分 2023-12-13 加入
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
16天前
已完结
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States
20天前
已完结
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
24天前
已关闭
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Emerging Pharmacotherapies for Obesity: A Systematic Review
1个月前
已完结
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
1个月前
已完结
Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
1个月前
已完结
Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials
1个月前
已完结
Glucagon, from past to present: a century of intensive research and controversies
1个月前
已完结
皖公网安备34019202002308
